Aims & Scope

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology.

It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.

The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.

While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 6.1
2024 5.30

Journal Rank

Year Value
2024 1378

Journal Citation Indicator

Year Value
2024 1284

SJR (SCImago Journal Rank)

Year Value
2024 2.043

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 45

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
6.1
First Published: 2025

SJR (SCImago Journal Rank)

SJR
2.043
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields